Correlation Between Beta Drugs and Silgo Retail

Can any of the company-specific risk be diversified away by investing in both Beta Drugs and Silgo Retail at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beta Drugs and Silgo Retail into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Beta Drugs and Silgo Retail Limited, you can compare the effects of market volatilities on Beta Drugs and Silgo Retail and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beta Drugs with a short position of Silgo Retail. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beta Drugs and Silgo Retail.

Diversification Opportunities for Beta Drugs and Silgo Retail

-0.11

Correlation Coefficient

Beta Drugs  Silgo Retail

Good diversification

The 3 months correlation between Beta and Silgo is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Beta Drugs and Silgo Retail Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Silgo Retail Limited and Beta Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beta Drugs are associated (or correlated) with Silgo Retail. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Silgo Retail Limited has no effect on the direction of Beta Drugs i.e., Beta Drugs and Silgo Retail go up and down completely randomly.

Pair Corralation between Beta Drugs and Silgo Retail

Assuming the 90 days trading horizon Beta Drugs is expected to generate 168.88 times less return on investment than Silgo Retail. But when comparing it to its historical volatility, Beta Drugs is 1.27 times less risky than Silgo Retail. It trades about 0.0 of its potential returns per unit of risk. Silgo Retail Limited is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  3,791  in Silgo Retail Limited on December 23, 2024 and sell it today you would earn a total of  731.00  from holding Silgo Retail Limited or generate 19.28% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Beta Drugs  vs.  Silgo Retail Limited

Beta Drugs

Risk-Adjusted Performance

Very Weak

Over the last 90 days Beta Drugs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Beta Drugs is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Silgo Retail Limited

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Silgo Retail Limited are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent essential indicators, Silgo Retail displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Beta Drugs and Silgo Retail

The main advantage of trading using opposite Beta Drugs and Silgo Retail positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beta Drugs position performs unexpectedly, Silgo Retail can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silgo Retail will offset losses from the drop in Silgo Retail's long position.

The idea behind Beta Drugs and Silgo Retail Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.